Pacira Biosciences Inc (PCRX)

Cost of Revenue

$44.16M

Quarterly · Period ending: · USD

PCRX logo

PCRX Cost of Revenue

Latest reported$44.16M
PCRX Quarterly Cost of Revenue ($2.72M → $44.16M)
High-resolution chart · PNG

PCRX cost of revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Pacira Biosciences Inc Cost of Revenue — Quarterly (USD)
Period endingCost of Revenue (USD)
44,164,000
36,413,000
40,299,000
34,278,000
40,866,000
34,306,000
39,886,000
38,864,000
44,262,000
47,416,000
47,692,000
39,750,000
48,207,000
49,020,000
61,916,000
50,678,000
50,627,000
36,074,000
39,007,000
34,651,000
35,248,000
31,349,000
35,297,000
29,993,000
22,305,000
29,732,000
31,903,000
22,304,000
25,201,000
27,303,000
23,979,000
19,065,000
20,916,000
22,885,000
21,295,000
18,228,000
23,811,000
24,581,000
23,621,000
43,152,000
23,053,000
20,278,000
19,427,000
15,901,000
18,929,000
17,580,000
18,968,000
20,391,000
19,954,000
18,127,000
18,376,000
14,791,000
10,214,000
11,391,000
9,672,000
9,287,000
6,685,000
6,495,000
6,601,000
3,357,000
3,115,000
3,667,000
2,108,000
3,573,000
2,849,000
3,746,000
3,478,000
2,719,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.